Research & Development

色播影音先锋色妊阁伊人在线伊人在线猫日本服务业增长放缓 市场乐观情绪缓和


  “皇帝的人找不到我們。”   雲瑯怔怔的瞅著驪山腳下的那片翠竹林,翠竹林上覆蓋了一些白雪。色播影音先锋   雲瑯冷笑道︰“三十萬金!”色妊阁伊人在线   雲瑯對皇帝的厭煩已經到了極致……他不覺得跟這位昔日的偶像再有什麼話可以平靜的說了。   甦稚笑道︰“我們出來的時候沒有帶護衛。”伊人在线猫   衛子夫的眼楮立刻瞪的極大,幾乎要從眼眶中凸出來了。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo